289 related articles for article (PubMed ID: 17201147)
1. Relationship between N-linked oligosaccharide chains of human serum immunoglobulin G and serum tumor markers with non-small cell lung cancer progression.
Kanoh Y; Ohara T; Mashiko T; Abe T; Masuda N; Akahoshi T
Anticancer Res; 2006; 26(6B):4293-7. PubMed ID: 17201147
[TBL] [Abstract][Full Text] [Related]
2. Changes to N-linked oligosaccharide chains of human serum immunoglobulin G and matrix metalloproteinase-2 with cancer progression.
Kanoh Y; Ohara T; Tadano T; Kanoh M; Akahoshi T
Anticancer Res; 2008; 28(2A):715-20. PubMed ID: 18507012
[TBL] [Abstract][Full Text] [Related]
3. Changes in serum IgG oligosaccharide chains with prostate cancer progression.
Kanoh Y; Mashiko T; Danbara M; Takayama Y; Ohtani S; Egawa S; Baba S; Akahoshi T
Anticancer Res; 2004; 24(5B):3135-9. PubMed ID: 15510601
[TBL] [Abstract][Full Text] [Related]
4. Serum Sialyl Lewis x and cytokeratin 19 fragment as predictive factors for recurrence in patients with stage I non-small cell lung cancer.
Mizuguchi S; Nishiyama N; Iwata T; Nishida T; Izumi N; Tsukioka T; Inoue K; Uenishi T; Wakasa K; Suehiro S
Lung Cancer; 2007 Dec; 58(3):369-75. PubMed ID: 17697728
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer.
Matsuoka K; Sumitomo S; Nakashima N; Nakajima D; Misaki N
Eur J Cardiothorac Surg; 2007 Sep; 32(3):435-9. PubMed ID: 17611117
[TBL] [Abstract][Full Text] [Related]
6. Clinical value of serum cytokeratin 19 fragment and sialyl-Lewis x in non-small cell lung cancer.
Mizuguchi S; Nishiyama N; Iwata T; Nishida T; Izumi N; Tsukioka T; Inoue K; Kameyama M; Suehiro S
Ann Thorac Surg; 2007 Jan; 83(1):216-21. PubMed ID: 17184666
[TBL] [Abstract][Full Text] [Related]
7. Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma.
Okada M; Nishio W; Sakamoto T; Uchino K; Yuki T; Nakagawa A; Tsubota N
Ann Thorac Surg; 2004 Sep; 78(3):1004-9; discussion 1009-10. PubMed ID: 15337038
[TBL] [Abstract][Full Text] [Related]
8. Serum sialyl lewis X-i antigen levels in non-small cell lung cancer: correlation with distant metastasis and survival.
Satoh H; Ishikawa H; Kamma H; Yamashita YT; Takahashi H; Ohtsuka M; Hasegawa S
Clin Cancer Res; 1997 Apr; 3(4):495-9. PubMed ID: 9815711
[TBL] [Abstract][Full Text] [Related]
9. Expression of CEA and trophoblastic cell markers by lung carcinoma in association with histological characteristics and serum marker levels.
Slodkowska J; Szturmowicz M; Rudzinski P; Giedronowicz D; Sakowicz A; Androsiuk W; Zakrzewska-Rowinska E
Eur J Cancer Prev; 1998 Feb; 7(1):51-60. PubMed ID: 9511851
[TBL] [Abstract][Full Text] [Related]
10. [Clinical value of CEA and CYFRA21-1 as an assessment indicator of therapeutic efficacy in advanced non-small cell lung cancer patients].
Li L; Song LH; Ding SC; Zhang XJ; Qiang L; Han CY; Yuan XT; Xu DD
Zhonghua Zhong Liu Za Zhi; 2010 Nov; 32(11):850-4. PubMed ID: 21223692
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the oligosaccharide chain of human serum immunoglobulin g in patients with localized or metastatic cancer.
Kanoh Y; Mashiko T; Danbara M; Takayama Y; Ohtani S; Imasaki T; Abe T; Akahoshi T
Oncology; 2004; 66(5):365-70. PubMed ID: 15331923
[TBL] [Abstract][Full Text] [Related]
12. Serum tenascin-C as a potential predictive marker of angiogenesis in non-small cell lung cancer.
Ishiwata T; Takahashi K; Shimanuki Y; Ohashi R; Cui R; Takahashi F; Shimizu K; Miura K; Fukuchi Y
Anticancer Res; 2005; 25(1B):489-95. PubMed ID: 15816617
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of preoperative serum sialyl Lewis X-i antigen levels in non-small cell lung cancer.
Satoh H; Ishikawa H; Yamashita YT; Takahashi H; Ishikawa S; Kamma H; Ohtsuka M; Hasegawa S
Anticancer Res; 1998; 18(4B):2865-8. PubMed ID: 9713476
[TBL] [Abstract][Full Text] [Related]
14. [Clinical usefulness of a new tumor marker CYFRA21-1 in patients with lung cancer].
Li R; Li R; Wang Y
Zhonghua Jie He He Hu Xi Za Zhi; 1998 Jan; 21(1):26-9. PubMed ID: 11263296
[TBL] [Abstract][Full Text] [Related]
15. [Usefulness of CYFRA21-1 as a tumor marker of non-small-cell lung cancer].
Tan Y; Zhang P; Zheng C
Zhonghua Zhong Liu Za Zhi; 1999 Jul; 21(4):287-9. PubMed ID: 11776818
[TBL] [Abstract][Full Text] [Related]
16. Utility of serum cytokeratin 19 fragment (CYFRA 21-1) and carcinoembryonic antigen (CEA) as tumour markers for non-small cell lung cancer.
Chantapet P; Riantawan P; Lebnak P; Getngern P
J Med Assoc Thai; 2000 Apr; 83(4):383-91. PubMed ID: 10808698
[TBL] [Abstract][Full Text] [Related]
17. Fuzzy logic-based tumor marker profiles including a new marker tumor M2-PK improved sensitivity to the detection of progression in lung cancer patients.
Schneider J; Peltri G; Bitterlich N; Neu K; Velcovsky HG; Morr H; Katz N; Eigenbrodt E
Anticancer Res; 2003; 23(2A):899-906. PubMed ID: 12820320
[TBL] [Abstract][Full Text] [Related]
18. [Significance of combined determination of CK19mRNA, carcinoembryanic antigen, neuron-specific enolase, and tissue polypeptide antigen in peripheral blood of patients with lung cancer].
Pan QR; Zhang X; Xu ZF; Zheng S
Ai Zheng; 2002 Feb; 21(2):196-9. PubMed ID: 12479076
[TBL] [Abstract][Full Text] [Related]
19. The prognostic value of serum epidermal growth factor receptor level in patients with non-small cell lung cancer.
Ciledağ A; Kaya A; Yetkin O; Poyraz B; Savaş I; Numanoğlu N; Savaş H
Tuberk Toraks; 2008; 56(4):390-5. PubMed ID: 19123074
[TBL] [Abstract][Full Text] [Related]
20. [Correlation between the mRNA levels of carcinoembryonic antigen and cytokeratin 19 in peripheral blood with staging, treatment response and prognosis in patients with lung cancer].
Wang JH; Zhang SC; Liu ZD; Chen XY; Li CY; Han Y; Ma Y
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Nov; 28(11):773-6. PubMed ID: 16324274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
